Dear HIFA colleagues,
We at Open Pharma are delighted to share that we have recently published our recommendations on developing and sharing plain language summaries of peer-reviewed medical journal publications.
We believe medical research is for everyone and plain language summaries of research publications are a means of sharing research in an accessible and inclusive way. Some of the key points from our recommendations highlight that plain language summaries should be:
Targeted toward a broad, inclusive and non-technical, non-specialist, or time-challenged audience
Written in easily understandable, unbiased language that is free of expert or technical jargon and accessible to readers who may have a different first language to that of the summary
Text based and concise (of 250 words or fewer) – this allows for indexing in directories such as PubMed and facilitates straightforward translation.
You can read more here: https://www.tandfonline.com/doi/full/10.1080/03007995.2021.1971185 and please do join in the discussions on twitter at @_OpenPharma or on LinkedIn.
Open Pharma is a multi-sponsor collaboration of pharmaceutical companies, non-pharmaceutical funders, publishers, patients, academics, regulators, editors, and societies seeking to identify and drive positive changes in the publishing of pharmaceutical company-funded research.
Adeline Rosenberg MSc
Oxford PharmaGenesis Ltd is registered in England and Wales, registration number 03488862. Our registration office is at Tubney Warren Barn, Tubney, Oxford, OX13 5QJ, UK. This message and any attachments are confidential and the information may be used only for the purpose for which it has been sent. If this message has been sent to you in error, please contact the sender as soon as possible.
HIFA profile: Adeline Rosenberg is a Medical Writer with Oxford PharmaGenesis, United Kingdom. Interests: Medical publishing, science communication, patient engagement, plain language summaries. adeline.rosenberg AT pharmagenesis.com